Close
Nordic 9Nordic 9

BioMedPartners (investor - Venture Capital)

Switzerland biomedvc.com
See something wrong or missing? Let us know
Offices:Basel
Average round investment:49.1M USD
Average number per year:2.3
Distribution: 2025 (1)2024 (2)2023 (1)2022 (5)2021 (1) See the entire list
Portfolio companies: Germany T-curxSwitzerland ImmunOs TherapeuticsGermany Tubulis See the entire list
Mostly invests in: Germany Germany (5) Health services (14)
See the entire list

Showing 3 of 14 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

BioMedPartners mostly invests with:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to BioMedPartners

Name Criteria
France Financière Arbevel
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 2.3
  • Active last 12 months: Yes
United States Benhamou Global Ventures
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Germany, Netherlands, France
  • Average number of deals per year: 2.3
  • Active last 12 months: Yes
Switzerland Swiss Entrepreneurs Fund
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 2.2
  • Active last 12 months: Yes
Belgium SRIW
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: France, Belgium
  • Average number of deals per year: 2.5
  • Active last 12 months: Yes
United States Foresite Capital
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Netherlands Icos Capital Management
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: Netherlands, France
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Japan Takeda Pharmaceutical Company Limited
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Netherlands, France
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
France IDIA Capital Investissement
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
United States Accenture
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Germany, Switzerland, France
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
United States Cargill
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Germany, Switzerland, Netherlands, France
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
Top